Saturday, June 13, 2026

pharma · Nasopharyngeal Carcinoma · Hepatocellular Carcinoma

Chinese Academy of

Chinese Academy of clinical programs — 1328 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

China, TAIZHOU, CN HQ
170 Employees
NMPA registrant Type
Company details
Status
Public
HQ
China, TAIZHOU, CN
Employees
170
Programs
1328
Drugs
711
Patents
335
Intelligence · Clinical Programs

Chinese Academy of projects

1,328 ClinicalTrials.gov programs sponsored by Chinese Academy of.

Chinese Academy of has 1,328 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

Page 19 of 28
  1. Edaravone Dexborneol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chemo Brain

    approved small molecule active

    1 trial
  2. Edoxaban

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-Valvular Atrial Fibrillation

    approved small molecule completed

    1 trial
  3. Eldecalcitol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Osteoporosis in Postmenopausal Women

    approved small molecule completed

    1 trial
  4. Empagliflozin 10 MG

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pre-Heart Failure

    approved small molecule active

    1 trial
  5. Enhanced dermatologic management

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    NSCLC (Advanced Non-small Cell Lung Cancer)

    approved other active

    1 trial
  6. Entecavir+Fuzheng Huayu+TCM Granule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B Virus Related Cirrhosis

    approved small molecule active

    1 trial
  7. Entecavir, Adefovir

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Hepatitis B

    approved small molecule active

    1 trial
  8. Epirubicin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Carcinoma, Hepatocellular

    approved small molecule active

    1 trial
  9. Etoposide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Mantle Cell Lymphoma

    approved small molecule completed

    1 trial
  10. Exenatide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Type 2 Diabetes Mellitus

    approved small molecule completed

    1 trial
  11. Ferric derisomaltose

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Heart Failure With Preserved Ejection Fraction

    approved small molecule active

    1 trial
  12. Ferric derisomaltose

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Heart Failure With Reduced Ejection Fraction

    approved small molecule active

    1 trial
  13. Fespixon Cream

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Diabetic Foot Ulcer (DFU)

    approved small molecule terminated

    1 trial
  14. Fluoxetine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Depressive Disorder

    approved small molecule active

    1 trial
  15. FuKe Qianjin Capsules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Endometritis

    approved small molecule active

    1 trial
  16. Glycopyrronium

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Postoperative Nausea and Vomiting

    approved small molecule active

    1 trial
  17. Group A (the standard 2HRZE/4HR regimen)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pulmonary Tuberculosis TB in Sputum: (+) Microscopy

    approved small molecule completed

    1 trial
  18. Guilingji Capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Oligospermia

    approved small molecule active

    1 trial
  19. Guli capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Knee Osteoarthritis

    approved small molecule active

    1 trial
  20. Hemodialysis with Polymethylmethacrylate Artificial Kidney

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Uremia

    approved other completed

    1 trial
  21. ICS+LABA

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Bronchiectasis

    approved small molecule completed

    1 trial
  22. Imipenem

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sepsis

    approved small molecule active

    1 trial
  23. Inactivated COVID-19 vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19

    approved mab active

    1 trial
  24. Inactivated Polio Vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Vaccination

    approved mab completed

    1 trial
  25. Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    SARS-CoV-2 Infection

    approved mab active

    1 trial
  26. Insulin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pancreatitis, Acute

    approved small molecule active

    1 trial
  27. Intensive statin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Artery Disease

    approved small molecule active

    1 trial
  28. Isoniazid

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Tuberculosis, Pulmonary

    approved small molecule active

    1 trial
  29. Isoniazid Aminosalicylate Tablets

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Reinfection Pulmonary Tuberculosis

    approved small molecule active

    1 trial
  30. Jejunostomy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Gastric Cancer

    approved other active

    1 trial
  31. K9520

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Multiple Myeloma

    approved small molecule active

    1 trial
  32. Kanglaite Injection+Chemotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    NSCLC

    approved small molecule active

    1 trial
  33. LABA/LAMA or Placebo inhalation

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Bronchiectasis Adult

    approved small molecule active

    1 trial
  34. Ledipasvir 90mg/Sofosbuvir 400 mg

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    approved small molecule terminated

    1 trial
  35. Lithium Carbonate 250 MG

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sleep Deprivation

    approved small molecule completed

    1 trial
  36. Low-Molecular-Weight Heparins Calcium Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pneumonia

    approved small molecule completed

    1 trial
  37. MIYAIRI 588

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Depression Mild

    approved small molecule completed

    1 trial
  38. Measles-Rubella combined vaccine(MR)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Measles

    approved mab completed

    1 trial
  39. Methylprednisolone and Mycophenolate mofetil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Autoimmune Hepatitis

    approved small molecule active

    1 trial
  40. Metronidazole vaginal suppositories

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Bacterial Vaginosis

    approved small molecule active

    1 trial
  41. Micafungin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Aspergillosis

    approved small molecule terminated

    1 trial
  42. Mifepristone tablets

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Uterine Fibroid

    approved small molecule terminated

    1 trial
  43. Misoprostol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Labor

    approved small molecule active

    1 trial
  44. Mobile Surgical Vehicle Echocardiography-guided ASD closure Group

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    ASD - Atrial Septal Defect

    approved other active

    1 trial
  45. Nafamostat mesilate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sepsis

    approved small molecule active

    1 trial
  46. Naldebain

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Postoperative Pain

    approved small molecule active

    1 trial
  47. NextDose (nextdose.org)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Thrombosis Embolism

    approved other active

    1 trial
  48. Nicorandil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-obstructive Coronary Artery Disease

    approved small molecule terminated

    1 trial

Frequently asked questions

How many clinical projects does Chinese Academy of have?

1,328 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.